Home / Resource Library / EFFICACY AND SAFETY OF ZANUBRUTINIB VERSUS RITUXIMAB-BASED CHEMOIMMUNOTHERAPY IN WALDENSTROM MACROGLOBULINEMIA: MATCHING-ADJUSTED INDIRECT COMPARISONS
EFFICACY AND SAFETY OF ZANUBRUTINIB VERSUS RITUXIMAB-BASED CHEMOIMMUNOTHERAPY IN WALDENSTROM MACROGLOBULINEMIA: MATCHING-ADJUSTED INDIRECT COMPARISONS